Kannalife Sciences, Inc.

Kannalife Sciences, Inc. is a pharmaceutical company working on a treatment for related brain disease called Chronic Traumatic Encephalopathy (CTE).

  • Stage Product In Development
  • Industry Biotechnology
  • Location New York, NY, US
  • Currency USD
  • Founded August 2010
  • Employees 5
  • Incorporation Type C-corp
  • Website kannalife.com

Company Summary

Kannalife Sciences, Inc. is a pharmaceutical company (located in Doylestown and associated with Temple University) currently working on a treatment for the concussion related brain disease called Chronic Traumatic Encephalopathy (CTE).

In 2012 we acquired the exclusive license from NIH for the use of the US Patent 6630507 “Cannabinoids as Antioxidants and Neuroprotectants”.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free